MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,687,300 | +3204.9% | 1,768,730 | +4008.0% | 0.00% | – |
| Q2 2023 | $535,186 | -93.2% | 43,056 | -92.3% | 0.00% | -100.0% |
| Q1 2023 | $7,870,215 | +0.8% | 561,757 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $7,805,847 | -83.9% | 545,482 | -71.3% | 0.00% | -81.8% |
| Q3 2022 | $48,531,000 | +556.4% | 1,900,965 | +630.6% | 0.01% | +450.0% |
| Q2 2022 | $7,393,000 | -63.6% | 260,209 | -54.8% | 0.00% | -50.0% |
| Q1 2022 | $20,327,000 | +36.0% | 576,291 | +61.5% | 0.00% | +33.3% |
| Q4 2021 | $14,950,000 | -79.3% | 356,803 | -75.7% | 0.00% | -80.0% |
| Q3 2021 | $72,074,000 | +132.9% | 1,468,499 | +98.0% | 0.02% | +150.0% |
| Q2 2021 | $30,952,000 | +131.0% | 741,713 | +97.2% | 0.01% | +100.0% |
| Q1 2021 | $13,402,000 | -59.6% | 376,038 | -68.2% | 0.00% | -66.7% |
| Q4 2020 | $33,212,000 | – | 1,184,029 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |